• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

科瑞法缓释片联合可多拿、曲帕胺和开博通治疗动脉高血压患者的临床疗效

[The clinical efficacy of Korinfar-retard in combination with Cordanum, triampur and Capoten in patients with arterial hypertension].

作者信息

Kukes V G, Ignat'ev V G, Pavlova L I, Rumiantsev A S, Pavlov S S, Privalov A N, Chil'tsov V V

出版信息

Klin Med (Mosk). 1996;74(2):20-3.

PMID:8772094
Abstract

Corinfar-retard as a base of different combinations with triampur, Cordanum, Capoten were studied in 52 patients with stable arterial hypertension (systolic pressure > 180 mm Hg, diastolic pressure > 105 mm Hg). In the above combinations pharmacokinetics of corinfar-retard did not change. Good response was noted in corinfar-retard combination with Cordanum in patients with moderate hemodynamic changes, hypertonicity of sympathoadrenal system, tachycardia. In patients with impaired myocardial contractility, elevated total peripheral vascular resistance, noticeable hypotensive effects was registered in combination with triampur. The absence of hypotensive effect in the above combination required the addition of Capoten which was absolutely indicated in patients with stable increase in plasma renin activity.

摘要

对52例稳定型动脉高血压患者(收缩压>180 mmHg,舒张压>105 mmHg)研究了缓释可力丁与曲帕胺、可多胺、卡托普利不同组合的情况。在上述组合中,缓释可力丁的药代动力学未发生改变。在血流动力学变化中等、交感肾上腺系统亢进、心动过速的患者中,缓释可力丁与可多胺组合显示出良好疗效。在心肌收缩力受损、总外周血管阻力升高的患者中,与曲帕胺组合有明显的降压作用。上述组合中无降压作用时需加用卡托普利,这对血浆肾素活性持续升高的患者绝对适用。

相似文献

1
[The clinical efficacy of Korinfar-retard in combination with Cordanum, triampur and Capoten in patients with arterial hypertension].科瑞法缓释片联合可多拿、曲帕胺和开博通治疗动脉高血压患者的临床疗效
Klin Med (Mosk). 1996;74(2):20-3.
2
[A pharmacokinetic study of korinfar-retard in monotherapy and in combination with cordanum and triampur in patients with arterial hypertension].[科林法缓释片单药治疗以及与可多纳和曲安普明联合治疗高血压患者的药代动力学研究]
Eksp Klin Farmakol. 1994 Nov-Dec;57(6):50-2.
3
[The pharmacokinetics of different drug forms of nifedipine when used singly and in a course as monotherapy and in combination with Cordanum and triampur preparations in patients with arterial hypertension].
Eksp Klin Farmakol. 1995 Nov-Dec;58(6):22-5.
4
[The use of the delayed-action form of korinfar in arterial hypertension, stenocardia and hypertrophic cardiomyopathy].[korinfar延迟作用剂型在动脉高血压、心绞痛和肥厚型心肌病中的应用]
Ter Arkh. 1996;68(1):39-42.
5
[The use of Cordanum in combination with Corinfar-Retard for the treatment of ectopic arrhythmias in the sick sinus syndrome in patients with ischemic heart disease].[可多胺与缓释可立复联合用于治疗缺血性心脏病患者病态窦房结综合征中的异位心律失常]
Ter Arkh. 1997;69(9):59-61.
6
[Triamterene in the treatment of hypertension with hydrochlorothiazide and propranolol (author's transl)].氨苯蝶啶与氢氯噻嗪及普萘洛尔联合治疗高血压(作者译)
Dtsch Med Wochenschr. 1977 Oct 28;102(43):1541-6. doi: 10.1055/s-0028-1105534.
7
Antihypertensive action of drug combination: Timolol, hydralazine, hydrochlorothiazide and triamterene.
Ann Clin Res. 1981 Feb;13(1):6-10.
8
A randomised crossover comparison of reserpine and sustained-release nifedipine in hypertension.利血平和缓释硝苯地平治疗高血压的随机交叉对照研究
Cent Afr J Med. 1997 Dec;43(12):344-9.
9
Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.缬沙坦联合氢氯噻嗪与氨氯地平单药治疗对伴有其他心血管危险因素的高血压患者的疗效及耐受性比较:VAST研究
Clin Ther. 2005 May;27(5):578-87. doi: 10.1016/j.clinthera.2005.05.006.
10
Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.非洛地平缓释片与传统利尿剂疗法治疗老年患者收缩期高血压的比较。国家试验组。
Clin Invest Med. 1998 Jun;21(3):142-50.